AI Medical Billing Automation Startup mutex Secures 281 Million Yen in Series A Funding

Funding Overview

mutex Inc. has raised a total of 281.6 million yen in a Series A round through a third-party allotment of shares. The round's underwriters include MTI Ltd., MEDIPAL Innovation Investment Limited Partnership (the corporate venture capital fund of MEDIPAL Holdings Corporation), and Nippon Keiei Co., Ltd. This latest financing brings the company's total funding to date to 341.6 million yen.

Background and Business Overview

In medical settings, complex reimbursement systems and labor shortages have made medical billing operations heavily reliant on the individual experience and tacit knowledge of administrative staff. mutex offers "Reze," an AI-powered medical billing support SaaS that ingests data from existing billing systems and electronic medical records. The AI automatically detects missed calculations and discrepancies, helping to streamline pre-claim audits.

Purpose of Funding and Future Outlook

The newly raised capital will be allocated toward expanding paid adoptions by medical institutions and accelerating product development. Moving forward, mutex aims to expand its functionality from point-based automation—focusing on audit support—to end-to-end automation covering creation and submission, ultimately helping medical institutions stabilize revenues and reduce operational burdens.

Recruitment and Exhibition Plans

mutex is currently ramping up its recruitment efforts, focusing primarily on engineers and individuals with medical administration experience. Additionally, the company is scheduled to exhibit at the 2nd Medical DX Expo [Tokyo], to be held at Makuhari Messe starting October 7, 2026.